Market share of diabetes drugs Saudi Arabia 2022, by brand

Published by Salma Saleh, Apr 9, 2024
Ozempic had the largest market share of anti-diabetes drugs in Saudi Arabia in 2022 based on revenue, at about 15 percent. Other market leaders in the country include Januvia and Novorapid, which own four percent of the anti-diabetes drug market each.

Market share of anti-diabetes drugs based on revenue in Saudi Arabia in 2022, by brand

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Supplementary notes

Data provided by Statista Market Insights are estimates.

Citation formats
Use Statista now: unlimited access to all content

Statistics on " Diabetes in the Middle East and North Africa region "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Diabetes in the Middle East and North Africa region

Global overview

7

Prevalence of diabetes in MENA

6

Prevalence of obesity in MENA

8

Diabetes medication and spending in MENA

7

Further Content: You might find this interesting as well

Topics

Diabetes in MENAObesity worldwideDiabetesHealthcare in the Middle EastSmoking in the MENA region
Use Statista now: unlimited access to all content
Learn more about how Statista can support your business.